Jaguar has built its final combustion-powered car, with the F-Pace marking the end of the brand’s gas era ahead of its ...

ThatDudeInBlue examines how Jaguar’s newest ad may harm the brand’s image. 3 police officers shot 'without warning' while ...

It’s been over a year since Jaguar faced a flurry of online abuse with its “Copy Nothing” campaign. It was supposed to be a ...

Mission accomplished, Jaguar. You have our attention. Along with that of Stephen Colbert, the gay-panic shit-stirrers at Fox News, X-man Elon and every hot-take purveyor from London to Los Angeles.

Jaguar Land Rover (JLR), a subsidiary of Tata Motors, announced Monday that it will partially resume manufacturing operations in the coming days. This decision follows a crippling cyberattack earlier ...

Tata Motors owns Jaguar Land Rover, has yet again extended the shutdown of its manufacturing facilities till October 1. The action from the manufacturer comes following a cyberattack a few weeks back.

ESSA Pharma (NASDAQ:EPIX) fell above 18% premarket on Wednesday after the company revised terms of its merger with biotech firm XenoTherapeutics, lowering expected shareholder payout due to potential ...

Tata Motors-owned Jaguar Land Rover (JLR) has extended its production halt for another week as it continues to deal with a cyberattack that occurred more than two weeks ago. The British luxury ...

JLR had in 2023 signed a five-year, £800 million contract with Tata Consultancy Services to provide cybersecurity and IT support as part of its digital transformation programme. Tata-owned British ...

Vehicle and engines output at JLR was suspended for much of September after a cyber-attack in late August Tata-owned Jaguar Land Rover (JLR) has confirmed that a recent cyber-attack has impacted its ...

For as long as the motorcar has ruled the roads, leather has been a hallmark of luxury when it comes to interiors. Versatile, comfortable and durable, it’s stood the test of time as the material of ...

ESSA is a pharmaceutical company that was previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit ...